
Implanet
Technopole Bordeaux Montesquieu Allée François Magendie, Martillac, Aquitaine, 33650, France
Overview
Implanet is launching a capital increase that will allow existing shareholders to acquire additional shares while maintaining their preferential subscription rights (DPS). The offer sets a subscription price of €0.250 per new share, a 29.2% discount to the closing share price of €0.353 on 8 October 2025 and a 26.5% discount to the theoretical ex-right price. One new share will be issued for every seven DPS held, targeting gross proceeds of €4.49 million. A 15% extension clause could raise the total to €5.16 million if fully exercised. The DPS will detach on 14 October 2025, and subscriptions will be accepted from 16 to 29 October 2025. Irrevocable subscription and guarantee commitments already cover 100% of the €4.49 million base amount. The article does not disclose information on Implanet’s products, revenues, user base, or longer-term strategic plans.
- Total raised
- $16M
- Funding rounds
- 2
- Latest round
- Equity
- Latest activity
- Oct 2025
Industries
- Biotechnology
- Health Care
- Medical Device
Recent funding
Equity
Oct 2025
$5M
Equity
Apr 2010
$11M